Metastatic Colorectal Cancer: Targeting Key Clinical Issues for Oncology Nurses

Released On
January 11, 2023

Expires On
January 11, 2024

Media Type
Internet

Completion Time
90 minutes

Specialty
Hematology-Oncology, Medical Oncology, Surgical Oncology

Topic(s)
Colon Cancer, Geriatric Medicine

Scroll to the Bottom of this Information to Begin this Course

This activity is provided by American Academy of CME, Inc.

This activity is supported in part by independent education grants from Taiho Oncology, Sirtex and Johnson & Johnson Medical Device Business Services.

Credit Available

  • Nurses — 1.5 Nursing Contact Hours (1.35 pharmacotherapeutic contact hours)

All other healthcare professionals completing this course will be issued a statement of participation.

Target Audience

This activity is designed to meet the educational needs of oncology nurses, nurse practitioners and nurse navigators engaged in the care of patients with metastatic colorectal cancer.

Program Overview

New targeted therapies for metastatic colorectal cancer have increased the need for awareness, education, and training for oncology nursing professionals to better prepare them to confidently manage and educate patients.

Learning Objectives

Upon completion of this activity, participants should be better able to:

  • Assess appropriate treatment options for a patient with mCRC who has failed first- and second-line treatment regimens
  • Outline toxicities and management considerations with specific treatment regimens for a patient with mCRC who has failed first- and second- line treatment regimens
  • Identify non-clinical barriers to effective patient care and resources to address them in a patient with mCRC

 

Faculty

Marianne D. Gault, MSN, BS, RN, OCN

Oncology Nurse Navigator
Ann B. Barshinger Cancer Institute


Physician Accreditation Statement

In support of improving patient care, American Academy of CME, Inc. is Jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Credit Designation

American Academy of CME, Inc., designates this educational activity for 1.5 ANCC contact hours (1.35 pharmacotherapeutic contact hours).

California
Provider approved by the California Board of Registered Nursing, Provider Number CEP16993 for 1.5 contact hours.

Disclosures of Conflicts of Interest

Faculty/Planner: Marianne D. Gault, MSN, BS, RN, OCN has no relevant relationships with ineligible companies to report.

Planners: Wendy Gloffke, PhD; John JD Juchniewicz, MCIS, CHCP, FACEHP; Natalie Kirkwood, RN, BSN, JD; Paul J Miniter, MS: no relevant relationships with ineligible companies to report.

Instructions for Participation and Credit

There are no fees for participating and receiving CME credit for this enduring activity. To receive CNE credit participants must:

  1. Read the CME/CE information and faculty disclosures.
  2. Participate in the online activity.
  3. Submit the evaluation form.

Certificates will be emailed to the participant.

Course Viewing Requirements

Supported Browsers:
Internet Explorer 8.0+ for Windows 2003, Vista, XP, Windows 7, Windows 8.1 and above
Google Chrome 28.0+ for Windows, Mac OS, or Linux
Mozilla Firefox 23.0+ for Windows, Mac OS, or Linux
Safari 6.0+ for Mac OSX 10.7 and above

Supported Phones & Tablets:
Android 4.0.3 and above
iPhone/iPad with iOS 6.1 or above

Disclosure of Unlabeled Use

American Academy of CME, Inc requires that faculty participating in any CME activity disclose to the audience when discussing any unlabeled or investigational use of any commercial product or device not yet approved for use in the United States. There is no off-label discussion or discussion of investigational uses.

Disclaimer

This activity is designed for educational purposes. Participants have a responsibility to utilize this information to enhance their professional development to improve patient outcomes. Conclusions drawn by the participants should be derived from careful consideration of all available scientific information. The participant should use his/her clinical judgment, knowledge, experience, and diagnostic decision-making before applying any information, whether provided here or by others, for any professional use.

Implicit Bias
Defaulting to stereotypes about your patients may lead to a lack of trust and poor health outcomes. It is very important to treat each patient as a unique individual who may or may not hold beliefs associated with their backgrounds and circumstances. In addition to treating each patient as a unique individual, the nurse must strive to be aware of their own biases and endeavor not to let them influence the quality of care they provide.

Contact Information

For CME questions please contact: CEServices@academycme.org